Therapeutic Targets for Dry AMD: A Foundation Fighting Blindness Webinar for Eye Care Professionals

The Foundation Fighting Blindness will host a free webinar on Tuesday, October 3, 2023, at 7:00 p.m. ET. During the one-hour webinar, David Boyer, MD, will review and describe many of the current therapeutic targets for dry age-related macular degeneration (AMD) and geographic atrophy. His discussion will include diagnosing dry AMD in patients and a review of existing and developmental treatments. Dr. Boyer is Senior Partner at Retina-Vitreous Associates Medical Group and Adjunct Clinical Professor of Ophthalmology with the University of Southern California/Keck School of Medicine in Los Angeles.

Therapeutic Targets for Dry AMD: Proposed Agenda

• Diagnosis of dry AMD and identifying patients at risk of vision loss
• Current therapeutic targets including: multiple complement system targets, anti-oxidants, mitochondria, and cell replacement
• Profiles of existing dry AMD therapies
• Need for more therapies for various stages of disease

Course Instructor

David S. Boyer, MD, is a Board-certified ophthalmologist specializing in the treatment of diseases of the retina and vitreous. He is Senior Partner at Retina-Vitreous Associates Medical Group with offices in Los Angeles, Beverly Hills, North Hollywood, Torrance, Pasadena, Tarzana and Glendale, California. Dr. Boyer is an Adjunct Clinical Professor of Ophthalmology with the University of Southern California/Keck School of Medicine in Los Angeles. He has an extensive research background and is currently an investigator for various clinical trials. He is one of the leading retinal clinical researchers in the country for new treatments in macular degeneration and diabetic macular edema. A widely published author and avid lecturer, Dr. Boyer lectures nationally and internationally on retinal research and the innovative approach to the treatment of retinal diseases.

Audience

The webinar is open to all eye care professionals including: retinal specialists, ophthalmologists, optometrists, low-vision rehabilitation specialists, orientation and mobility specialists, and ophthalmic technicians.

This webinar is sponsored by Apellis Pharmaceuticals.